Clinical efficacy of neoadjuvant treatment on early stage bulky cervical carcinoma
10.3760/cma.j.issn.1008-1372.2016.12.010
- VernacularTitle:新辅助治疗对早期巨块型宫颈癌的临床疗效
- Author:
Mingfei GUAN
;
Anna ZHU
;
Yan LI
;
Li ZHOU
;
Yini WANG
;
Congzhu LI
;
Ping HUANG
- Keywords:
Chemotherapy,adjuvant;
Radiotherapy,adjuvant;
Uterine cervical neoplasms/TH
- From:
Journal of Chinese Physician
2016;18(12):1797-1800
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate clinical efficacy and survival outcomes of neoadjuvant treatment on early stage bulky cervical carcinoma.Methods A total of 155 cases with bulky stage Ⅰ b2 or Ⅱ a2 cervical carcinoma in Affiliated Tumor Hospital of Shantou University Medical College from Nov.2010 to Feb.2015 was reviewed and divided into two groups according to pre-operative treatment 108 cases in the neoadjuvant treatment group and 47 cases in the control group who underwent radical surgery directly.The clinical,pathologic,and follow-up data were analyzed retrospectively.Results The total response rate of neoadjuvant treatment was 75.0％.Histological grade in neoadjuvant treatment group was better than the other group and the rate of deep myometrial infiltration was tend to low in neoadjuvant treatment group.There was no difference in pathological type,parametrial involvement,lymph node metastasis,and lymph vascular space invasion between two groups.The rate of postoperative treatment was similar (92.6％ vs 87.2％,P ＞ 0.05).The overall survival rate of neoadjuvant treatment group was 96.4％ and the other group was 88.9％ (P =0.069).Conclusions Neoadjuvant treatment was effective for early stage bulky cervical carcinoma.It might reduce tumor histological grade and maybe improve the overall survival of patients.
